Technology
Health
Biotechnology

Benitec Biopharma

$2.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (1.01%) Today
+$0.02 (1.01%) Today

Why Robinhood?

You can buy or sell BNTC and other stocks, options, ETFs, and crypto commission-free!

About

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. Read More It operates through the Australia, and United States of America geographical segments. The company was founded in 1997 and is headquartered in North Sydney, Australia.

Employees
Headquarters
North Sydney, New South Wales (NSW)
Founded
1997
Market Cap
25.45M
Price-Earnings Ratio
23.31
Dividend Yield
Average Volume
29.12K
High Today
$2.00
Low Today
$2.00
Open Price
$2.00
Volume
500.00
52 Week High
$4.90
52 Week Low
$1.01

Collections

Technology
Health
Biotechnology
2015 IPO

News

Simply Wall StFeb 27

These Fundamentals Make Benitec Biopharma Limited (ASX:BLT) Truly Worth Looking At

Attractive stocks have exceptional fundamentals. In the case of Benitec Biopharma Limited (ASX:BLT), there’s is a company that has been able to sustain great financial health, trading at an attractive share price. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on Benitec Biopharma here. Flawless balance sheet and undervalued BLT’s ability to maintain an adequate le...

6
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.